LOGO
LOGO

Intraday Alerts

Cumberland Pharmaceuticals Stock Soars 44% Over $100 Mln Deal To Sell Branded Drugs To Apotex

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of Cumberland Pharmaceuticals Inc. (CPIX) are rising about 44 percent during Thursday morning trading following the company's agreement with an affiliate of Apotex to integrate their branded U.S. businesses.

The company's shares are currently trading at $4.4001 on the Nasdaq, up 44.29 percent. The stock opened at $5.75 and has climbed as high as $6.0399 so far in today's session. Over the past year, it has traded in a range of $1.8500 to $6.2700.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19